Three-year RP data showed durable efficacy: intravitreal AAV2 optogenetics improved ~3 ETDRS lines, while lentiviral PEDF ...
A newly developed diagnostic system, CaptureTumor (CaT), driven by artificial intelligence (AI) and designed specifically for ...
The FDA’s press release noted that the guidance supports development of an array of cell and gene therapy products, including ...
A clinic-based study of more than 6,000 Japanese adults has found that men who drink alcohol regularly develop advanced ...
European commercialization introduces an additional aflibercept biosimilar option for major retinal indications, potentially ...
TearSolutions, Inc. has announced that the FDA has granted both Orphan Drug Designation (ODD) and Fast Track Designation for ...
A case report describes image-guided surgical excision combined with adjunctive cryotherapy and a single anterior chamber methotrexate injection, with no recurrence at 10 months. A 69-year-old man ...
FDA clearance via 510(k) reflects substantial equivalence and safety, not proven gains in diagnostic accuracy, workflow efficiency, or patient outcomes versus prior SPECTRALIS configurations. A new ...
FDA approval covers capsular-bag implantation for adult aphakia correction with <1.0 D corneal astigmatism; a toric PureSee Toric II option targets ≥1.0 D astigmatism. Pivotal US randomized, masked, ...
Pineless is the Jerome and Joan Snyder Chair in Ophthalmology and director of the Residency Program at the University of California, Los Angeles Stein Eye Institute. She practices pediatric and ...
NORTHSTAR will evaluate the safety and efficacy of oral gildeuretinol to reduce formation of vitamin A dimers in patients with Stargardt disease. NORTHSTAR will enroll about 230 patients (8–45 years) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results